These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29601941)

  • 1. Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations.
    Dantas AT; Almeida AR; Sampaio MCPD; Cordeiro MF; Oliveira PSS; Mariz HA; Pereira MC; Rego MJBM; Pitta IDR; Duarte ALBP; Pitta MGDR
    Immunol Lett; 2018 Jun; 198():12-16. PubMed ID: 29601941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid inhibits chemokines production in systemic sclerosis patients.
    Dantas AT; de Almeida AR; Sampaio MCPD; Cordeiro MF; da Rocha LF; de Oliveira PSS; Pereira MC; de Melo Rego MJB; Marques CDL; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG
    Steroids; 2017 Nov; 127():24-30. PubMed ID: 28866045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients.
    de Almeida AR; Dantas AT; Pereira MC; Cordeiro MF; Gonçalves RSG; de Melo Rêgo MJB; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG
    Inflammopharmacology; 2019 Aug; 27(4):723-730. PubMed ID: 31069604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessing the Role of the Active TGF-
    Dantas AT; Gonçalves SM; de Almeida AR; Gonçalves RS; Sampaio MC; Vilar KM; Pereira MC; Rêgo MJ; Pitta ID; Marques CD; Duarte AL; Pitta MG
    Dis Markers; 2016; 2016():6064830. PubMed ID: 27965520
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
    Scala E; Pallotta S; Frezzolini A; Abeni D; Barbieri C; Sampogna F; De Pità O; Puddu P; Paganelli R; Russo G
    Clin Exp Immunol; 2004 Dec; 138(3):540-6. PubMed ID: 15544634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1β, IL-1α and Th17-associated cytokines and decrease of Th1 and Th2 cytokines.
    Ibrahim JN; Jounblat R; Delwail A; Abou-Ghoch J; Salem N; Chouery E; Megarbane A; Medlej-Hashim M; Lecron JC
    Cytokine; 2014 Oct; 69(2):248-54. PubMed ID: 25025954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease.
    Bielecki M; Kowal K; Lapinska A; Chwiesko-Minarowska S; Chyczewski L; Kowal-Bielecka O
    Adv Med Sci; 2011; 56(2):255-63. PubMed ID: 21983449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis.
    Bielecki M; Kowal K; Lapinska A; Chyczewski L; Kowal-Bielecka O
    Adv Med Sci; 2013; 58(1):126-33. PubMed ID: 23640944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis.
    Corrado A; Rotondo C; Sanpaolo ER; Altomare A; Maruotti N; Cici D; Cantatore FP
    Int J Med Sci; 2022; 19(5):867-877. PubMed ID: 35693738
    [No Abstract]   [Full Text] [Related]  

  • 10. IBPA a mutual prodrug of ibuprofen and acetaminophen alleviates inflammation, immune dysregulation and fibrosis in preclinical models of systemic sclerosis.
    Rodrigues de Almeida A; Jaime Bezerra Mendonça Junior F; Tavares Dantas A; Eduarda de Oliveira Gonçalves M; Chêne C; Jeljeli M; Chouzenoux S; Thomas M; David de Azevedo Valadares L; Andreza Bezerra Correia M; Ângela da Silva Alves W; Carvalho Lira E; Doridot L; Jesus Barreto de Melo Rêgo M; Cristiny Pereira M; Luzia Branco Pinto Duarte A; Saes Parra Abdalla D; Nicco C; Batteux F; Galdino da Rocha Pitta M
    Int Immunopharmacol; 2024 Jul; 136():112344. PubMed ID: 38833846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis.
    Fleury M; Belkina AC; Proctor EA; Zammitti C; Simms RW; Lauffenburger DA; Snyder-Cappione JE; Lafyatis R; Dooms H
    Arthritis Rheumatol; 2018 Apr; 70(4):566-577. PubMed ID: 29245183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.
    Brown M; Postlethwaite AE; Myers LK; Hasty KA
    Clin Rheumatol; 2012 Jun; 31(6):973-81. PubMed ID: 22367096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins Inhibit Cytokines in a Dose-Dependent Response in Patients with Systemic Sclerosis.
    Gonçalves RSG; Dantas AT; Pereira MC; de Almeida AR; Rego MJBM; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG
    Inflammation; 2019 Apr; 42(2):407-411. PubMed ID: 30288636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered B lymphocyte homeostasis and functions in systemic sclerosis.
    Forestier A; Guerrier T; Jouvray M; Giovannelli J; Lefèvre G; Sobanski V; Hauspie C; Hachulla E; Hatron PY; Zéphir H; Vermersch P; Labalette M; Launay D; Dubucquoi S
    Autoimmun Rev; 2018 Mar; 17(3):244-255. PubMed ID: 29343447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles.
    Carbone LD; Warrington KJ; Barrow KD; Pugazhenthi M; Watsky MA; Somes G; Ingels J; Postlethwaite AE
    Clin Exp Immunol; 2006 Dec; 146(3):371-80. PubMed ID: 17100755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis.
    Sato S; Hanakawa H; Hasegawa M; Nagaoka T; Hamaguchi Y; Nishijima C; Komatsu K; Hirata A; Takehara K
    J Rheumatol; 2000 Dec; 27(12):2838-42. PubMed ID: 11128673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
    Carvalheiro T; Affandi AJ; Malvar-Fernández B; Dullemond I; Cossu M; Ottria A; Mertens JS; Giovannone B; Bonte-Mineur F; Kok MR; Marut W; Reedquist KA; Radstake TR; García S
    Arthritis Rheumatol; 2019 Oct; 71(10):1711-1722. PubMed ID: 31012544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.
    Migalovich Sheikhet H; Villacorta Hidalgo J; Fisch P; Balbir-Gurman A; Braun-Moscovici Y; Bank I
    Front Immunol; 2018; 9():753. PubMed ID: 29706966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon system activation and association with disease manifestations in systemic sclerosis.
    Eloranta ML; Franck-Larsson K; Lövgren T; Kalamajski S; Rönnblom A; Rubin K; Alm GV; Rönnblom L
    Ann Rheum Dis; 2010 Jul; 69(7):1396-402. PubMed ID: 20472592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.